VTRS · Earnings call · 2026Q2T · Full report

Manufacturing and Capacity

Viatris Inc · 2026-08-06 · Importance 31 · Surprise 42

Viatris operates 26 manufacturing facilities globally and is increasing capacity at its Vermont site to address unusually strong estradiol-patch demand. Management is also considering external manufacturing resources in addition to expanding its own plant. The company plans to manufacture more higher-margin products, including complex generics, transdermal products and value-added medicines, in the United States. This manufacturing footprint is also intended to provide flexibility amid potential changes affecting generic-product supply.

Key facts